Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 11/20 | 0.57 |
| ▸ | LMNA | P02545 | 7/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.42 |
| ▸ | ZAP70 | P43403 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3433958 | 0.92 | LMNA (0.52) | MAPTLMNASMN1; SMN2TDP1ALDH1A1 | |
| SCHEMBL3433106 | 0.90 | MAPT (0.59) | MAPTLMNASMN1; SMN2TDP1ALDH1A1 | |
| SCHEMBL3435391 | 0.88 | HRH3 (0.49) | MAPTLMNASMN1; SMN2TDP1ALDH1A1 | |
| SCHEMBL3435399 | 0.87 | TP53 (0.54) | MAPTLMNASMN1; SMN2TDP1ALDH1A1 | |
| SCHEMBL3435380 | 0.86 | MAPT (0.50) | MAPTLMNASMN1; SMN2TDP1ALDH1A1 | |
| SCHEMBL3433113 | 0.86 | MAPT (0.60) | MAPTLMNASMN1; SMN2TDP1ALDH1A1 | |
| SCHEMBL3435827 | 0.84 | MAPT (0.48) | MAPTLMNASMN1; SMN2TDP1ALDH1A1 | |
| SCHEMBL3435386 | 0.84 | LMNA (0.58) | MAPTLMNASMN1; SMN2TDP1ALDH1A1 | |
| SCHEMBL2132174 | 0.84 | MAPT (0.66) | MAPTLMNASMN1; SMN2TDP1ALDH1A1 | |
| SCHEMBL3434552 | 0.84 | TP53 (0.53) | MAPTLMNASMN1; SMN2TDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8410163-B2 | Substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carbonitriles and substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carboxamides as tubulin polymerization inhibitors | TELIK, INC. (US) | 2013-04-02 | — | — | US | disclosed |
| US-20120101286-A1 | SUBSTITUTED 4-AMINO-5-BENZOYL-2-(PHENYLAMINO)THIOPHENE-3-CARBONITRILES AND SUBSTITUTED 4-AMINO-5-BENZOYL-2-(PHENYLAMINO)THIOPHENE-3-CARBOXAMIDES AS TUBULIN POLYMERIZATION INHIBITORS | TELIK INC. (US) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120101286-A1 | SUBSTITUTED 4-AMINO-5-BENZOYL-2-(PHENYLAMINO)THIOPHENE-3-CARBONITRILES AND SUBSTITUTED 4-AMINO-5-BENZOYL-2-(PHENYLAMINO)THIOPHENE-3-CARBOXAMIDES AS TUBULIN POLYMERIZATION INHIBITORS | TUBB3, TUBB4A, TUBB | MAPT 37/4885LMNA 2175/4885SMN1; SMN2 2182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.